Page results
-
The Integrated Children’s and Adolescent Service has been established to provide complementary care alongside orthodox treatments. The clinic sees children up to 18 years old with a wide variety of illnesses.
-
The Acute Stroke Unit (ASU) is the next step of care for stroke patients who come to the Hyper-acute Stroke Unit (HASU) at UCLH.
-
Our Brain Tumour Service is a pioneering specialist centre offering high-quality treatment and care to patients with all forms of brain or spinal tumours.
-
The movement disorders group specialises in the assessment, diagnosis and treatment of people with diseases such as Parkinson’s disease, dystonia, tremor, myoclonus and chorea.
-
The clinical management of neuromuscular muscle wasting diseases such as motor neuron disease, myasthenia gravis, muscular dystrophy and peripheral neuropathy.
-
The department is responsible for a wide range of neurophysiological procedures, principally electromyography (EMG) and nerve conduction studies, EMG-guided botulinum toxin (BoTox) injections, electroencephalography (EEG), evoked potentials (EPs) and intra-operative monitoring (IOM)
-
Skeletal uscle channelopathies are rare neuromuscular diseases that cause symptoms of episodic muscle weakness/paralysis or cause difficulty in relaxing muscles (the muscle can feel stuck or cramped) once they are contracted.
-
The spasticity service at NHNN offers a comprehensive, responsive multidisciplinary service to adults with spasticity associated with any neurological condition.
-
Autoimmune serology is provided for: Connective tissue diseases, Endocrine diseases, Liver diseases, Rheumatic diseases, Skin diseases, Thyroid diseases.
-
The Pathogen Genomic Unit offers access to explore the clinical applications and interpretation of pathogen genomic data for patients with a variety of infections.
File results
-
FOI/2024/0694 - Off-framework agency shifts/ spend/ contact details January-August 2024
-
FOI/2024/0702 - Community respiratory service mapping/ community-based bronchiectasis services
-
FOI/2024/0703 - Neurofibromatosis type 1 treatment/ volume of medication dispensed
-
FOI/2024/0704 - Contingencies to support visitors/ patients/ contractors witnessing a distressing event
-
FOI/2024/0716 - Toxicological screening/ testing/ training and information to patients
-
FOI/2024/0718 - Mental health/ electronic health records software/ dermatology screening/ imaging services/ medical devices for wound care
-
FOI/2024/0721 - New biologic and targeted medications/ treatment within dermatology
-
FOI/2024/0727 - Clinical photography solution contract/ spend
-
FOI/2024/0740 - A&E tooth decay admissions for 2021/22, 2022/23 and 2023/24
-
FOI/2024/0741 - HR, finance and payroll contracts/ software updates/ staff contact details